To determine the effect of Tris DBA palladium on ARF6 activation, we performed ARF6-GTP pulldown assays on Mel92.1 and Mel202 uveal melanoma cell lines that had been treated with concentrations of Tris DBA palladium ranging from 1 to 5 μM (Figure 4). This evidence concerns the gene ARF6 and uveal melanoma.